PamGene Licenses Tech to Innogenetics for Diagnostic Tests | GenomeWeb

NEW YORK, May 27 (GenomeWeb News) - PamGene has exclusively licensed its microarray technology to Innogenetics for development of multiple-parameter nucleic acid-and protein diagnostics in the area of infectious diseases, genetic testing and neurodegeneration, the companies said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.